Uploaded September 2025 | Updated September 2026, 4 hours ago
The data is clear: inflammatory bowel diseases like ulcerative colitis and Crohn’s are on the rise worldwide. In this episode, we sit down with Dr. Amy Lightner—VP of Clinical Development at Calibr-Skaggs and colorectal surgeon at Scripps Clinic—to explore what drives these diseases, an upcoming phase 2 clinical trial for a new regenerative medicine, and how she balances life between the operating room and the research lab.
Subscribe to Science Changing Life:
https://www.scripps.edu/news-and-events/podcast
Lightner lab:
https://lightner.scripps.edu/
Instagram: instagram.com/lightnerlab
LinkedIn: linkedin.com/in/amy-l-lightner-md-mba-14685512 Facebook: facebook.com/profile.php?id=61572564272091 Scripps Research Magazine: magazine.scripps.edu/
The data is clear: inflammatory bowel diseases like ulcerative colitis and Crohn’s are on the rise worldwide. In this episode, we sit down with Dr. Amy Lightner—VP of Clinical Development at Calibr-Skaggs and colorectal surgeon at Scripps Clinic—to explore what drives these diseases, an upcoming phase 2 clinical trial for a new regenerative medicine, and how she balances life between the operating room and the research lab.
Subscribe to Science Changing Life:
https://www.scripps.edu/news-and-events/podcast
Lightner lab:
https://lightner.scripps.edu/
Instagram: instagram.com/lightnerlab
LinkedIn: linkedin.com/in/amy-l-lightner-md-mba-14685512 Facebook: facebook.com/profile.php?id=61572564272091 Scripps Research Magazine: magazine.scripps.edu/
